| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.2 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.2 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |